Retinal Rejuvenation Therapy (2RT) has been clinically proven to delay AMD progression!
In 76% of patients who have been treated with 2RT during the LEAD study, the progression rate of late AMD decreased by 77%.
Browse the Mediconsult product catalog 2018/19 online or order a printed version!
Subscribe to the Ophthalmo Experience Reports newsletter and be among the first to hear about our latest reports:
Ask our consultants for information and discover our offer:
Innovative cyclophotocoagulation with MicroPulse technology from Iridex
Comprehensive ophthalmology programmes
Since its founding in 1990, Mediconsult AG has remained true to its aspiration of providing eye specialists with high-quality products and perfected services. Our efforts to offer innovations and market-oriented services on a permanent basis have been rewarded with an assured market value. Our activities are divided up into the five areas of ophthalmology: